Discover

DCTH
Delcath Systems, Inc.
12.91
2 x 9.42
2 x 16.38
bid
ask
+
0.32
2.54%
2 @ 04:00 PM
13.10 +0.19 (1.47%)
Ytd27.82%
1y1.18%
12.46
day range
13.12
8.12
52 week range
13.44
Open12.62Prev Close12.59Low12.46High13.12Mkt Cap445.67M
Vol373.64KAvg Vol463.15KEPS0.01P/E1291.00Forward P/E-35.75
Beta0.76Short Ratio5.26Inst. Own38.13%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg11.30200-d Avg10.291yr Est21.33

DCTH News

benzinga.com
Delcath Systems Q1 EPS $(0.03) Beats $(0.10) Estimate, Sales $24.994M Beat $23.383M Estimate

Delcath Systems (NASDAQ:DCTH) reported quarterly losses of $(0.03) per share which beat the analyst

benzinga.com
Delcath Systems' CHEMOSAT M-PHP Recognized As Recommended Liver-Directed Therapy For Metastatic Uvea

Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on liver-directed ca

benzinga.com
BTIG Maintains Buy on Delcath Systems, Lowers Price Target to $19

BTIG analyst Marie Thibault maintains Delcath Systems (NASDAQ:DCTH) with a Buy and lowers the pri

benzinga.com
Delcath Systems FY2026 Total CHEMOSAT and HEPZATO KIT Revenue expected to be more than $100.000M vs

Delcath Systems (NASDAQ:DCTH) FY2026 Total CHEMOSAT and HEPZATO KIT Revenue expected to be more than

benzinga.com
Delcath Systems Q4 EPS $(0.05) Beats $(0.06) Estimate, Sales $20.728M Beat $20.326M Estimate

Delcath Systems (NASDAQ:DCTH) reported quarterly losses of $(0.05) per share which beat the analyst

Delcath Systems Q4 Earnings Assessment
benzinga.com
Delcath Systems Q4 Earnings Assessment

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

benzinga.com
HC Wainwright & Co. Reiterates Buy on Delcath Systems, Maintains $30 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Delcath Systems (NASDAQ:DCTH) w

Under the Radar: 3 Microcap Growers Passing a Tough Test
benzinga.com
Under the Radar: 3 Microcap Growers Passing a Tough Test

benzinga.com
Delcath Systems Publishes Phase 3 FOCUS Subgroup Analyses Showing Consistent Efficacy And Safety Of

Delcath Systems, Inc. (NASDAQ:DCTH), ("Delcath" or the "Company") an interventional

benzinga.com
Delcath Systems 10-Year Data From Retrospective Study On Patients With Liver-Dominant Metastatic Uve

Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional

10 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
10 Health Care Stocks With Whale Alerts In Today's Session

benzinga.com
Delcath Systems Announces $25M Buyback Plan

Delcath Systems, Inc. (NASDAQ:DCTH), ("Delcath") an interventional oncology company focused

benzinga.com
Delcath Systems Announces Retrospective Study From The University Of Tubingen, Analyzing Long-Term S

Delcath Systems, Inc. (NASDAQ:DCTH), ("Delcath" or the "Company") an interventional

benzinga.com
Stephens & Co. Maintains Overweight on Delcath Systems, Lowers Price Target to $18

Stephens & Co. analyst Sudan Loganathan maintains Delcath Systems (NASDAQ:DCTH) with a Overwe

benzinga.com
Delcath Systems Q3 EPS $0.02 Beats $0.01 Estimate, Sales $20.563M Miss $20.907M Estimate

Delcath Systems (NASDAQ:DCTH) reported quarterly earnings of $0.02 per share which beat the analyst

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

benzinga.com
Canaccord Genuity Maintains Buy on Delcath Systems, Maintains $21 Price Target

Canaccord Genuity analyst John Newman maintains Delcath Systems (NASDAQ:DCTH) with a Buy and main

benzinga.com
HC Wainwright & Co. Maintains Buy on Delcath Systems, Lowers Price Target to $30

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Delcath Systems (NASDAQ:DCTH) wi

Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

benzinga.com
Reported Saturday, Delcath Systems Posts $20.5M Q3 Revenue, $0.8M Net Income And 87% Gross Margin; S

Preliminary Third Quarter Financial Results (unaudited)Total CHEMOSAT and HEPZATO KIT revenue of app

benzinga.com
Delcath Systems Announces The Acceptance Of An Oral Presentation On Results From The Investigator-In

Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of

benzinga.com
HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $31

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Delcath Systems (NASDAQ:DCTH) wi

benzinga.com
Delcath Systems Q2 EPS $0.07 Beats $0.02 Estimate, Sales $24.16M Beat $22.83M Estimate

Delcath Systems (NASDAQ:DCTH) reported quarterly earnings of $0.07 per share which beat the analyst

benzinga.com
Earnings Scheduled For August 6, 2025

benzinga.com
Stephens & Co. Reiterates Overweight on Delcath Systems, Maintains $25 Price Target

Stephens & Co. analyst Sudan Loganathan reiterates Delcath Systems (NASDAQ:DCTH) with a Overw

Tesla To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Friday
benzinga.com
Tesla To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Friday

benzinga.com
HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $29

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Delcath Systems (NASDAQ:DCTH) wi

benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com
Earnings Scheduled For May 8, 2025

Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session

benzinga.com
Delcath Systems Receives FDA Clearance Of IND Application For Phase 2 Clinical Trial Of HEPZATO In L

Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of

benzinga.com
HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $24

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Delcath Systems (NASDAQ:DCTH) wi

benzinga.com
Delcath Systems Q4 2024 GAAP EPS $(0.11) Misses $(0.02) Estimate, Sales $15.10M Beat $13.78M Estimat

Delcath Systems (NASDAQ:DCTH) reported quarterly losses of $(0.11) per share which missed the analys

benzinga.com
Earnings Scheduled For March 6, 2025

benzinga.com
Craig-Hallum Maintains Buy on Delcath Systems, Raises Price Target to $21

Craig-Hallum analyst Chase Knickerbocker maintains Delcath Systems (NASDAQ:DCTH) with a Buy and r

benzinga.com
Analyst Expectations For Delcath Systems's Future

benzinga.com
HC Wainwright & Co. Reiterates Buy on Delcath Systems, Maintains $22 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Delcath Systems (NASDAQ:DCTH) w

benzinga.com
Delcath Systems Announces Q4 2024 Revenue At $15.1M, Full Year At $37.2M; HEPZATO Kit At $13.7M In Q

Fourth Quarter Revenue Approximately $15.1 Million and Full Year Total Revenue Approximately $37.2 M

benzinga.com
MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday

benzinga.com
Why Zoomcar Shares Are Trading Higher By Around 142%; Here Are 20 Stocks Moving Premarket

benzinga.com
Delcath Systems Announces FDA Clearance Of IND Application For Phase 2 Clinical Trial Of HEPZATO In

Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of

benzinga.com
HC Wainwright & Co. Reiterates Buy on Delcath Systems, Maintains $22 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Delcath Systems (NASDAQ:DCTH) w

benzinga.com
Delcath Systems Q3 2024 GAAP EPS $(0.06) Beats $(0.23) Estimate, Sales $11.20M Beat $10.46M Estimate

Delcath Systems (NASDAQ:DCTH) reported quarterly losses of $(0.06) per share which beat the analyst

benzinga.com
Uncovering Potential: Delcath Systems's Earnings Preview

benzinga.com
Analyst Scoreboard: 4 Ratings For Delcath Systems

benzinga.com
Canaccord Genuity Maintains Buy on Delcath Systems, Maintains $21 Price Target

Canaccord Genuity analyst John Newman maintains Delcath Systems (NASDAQ:DCTH) with a Buy and main

benzinga.com
HC Wainwright & Co. Reiterates Buy on Delcath Systems, Maintains $22 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Delcath Systems (NASDAQ:DCTH) w

benzinga.com
'This Is A Very Speculative Situation,' Jim Cramer On ADMA Biologics

"Mad Money" host Jim Cramer said, "Any time there's immunity-compromised patients, t

benzinga.com
Delcath Systems Publishes Retrospective Study By Independent Investigators In The Annals Of Surgical

Key Findings from the Study:Overall Survival (OS): The study reported median OS of 22.4 months for p